ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 128 filers reported holding ENDOLOGIX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,543,000 | -55.3% | 444,500 | 0.0% | 0.01% | -50.0% |
Q3 2016 | $5,689,000 | +10.9% | 444,500 | +7.9% | 0.01% | +9.1% |
Q2 2016 | $5,131,000 | +53.7% | 411,800 | +3.1% | 0.01% | +83.3% |
Q1 2016 | $3,338,000 | -15.6% | 399,300 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $3,953,000 | -70.8% | 399,300 | -63.9% | 0.01% | -72.7% |
Q3 2015 | $13,545,000 | +109.4% | 1,104,850 | +161.9% | 0.02% | +144.4% |
Q2 2015 | $6,470,000 | -10.1% | 421,782 | 0.0% | 0.01% | -10.0% |
Q1 2015 | $7,200,000 | +11.6% | 421,782 | 0.0% | 0.01% | +11.1% |
Q4 2014 | $6,449,000 | +8.2% | 421,782 | -25.0% | 0.01% | +12.5% |
Q3 2014 | $5,959,000 | -57.6% | 562,182 | -39.1% | 0.01% | -61.9% |
Q2 2014 | $14,048,000 | +18.2% | 923,600 | 0.0% | 0.02% | +16.7% |
Q1 2014 | $11,886,000 | -36.6% | 923,600 | -14.1% | 0.02% | -40.0% |
Q4 2013 | $18,752,000 | +8.1% | 1,075,200 | 0.0% | 0.03% | -9.1% |
Q3 2013 | $17,343,000 | +31.6% | 1,075,200 | +8.4% | 0.03% | +17.9% |
Q2 2013 | $13,176,000 | – | 992,200 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,121,447 | $5,450,000 | 2.37% |
Essex Woodlands Management, Inc. | 1,257,468 | $11,699,000 | 2.12% |
Redmile Group, LLC | 6,368,299 | $30,950,000 | 1.88% |
Camber Capital Management LP | 7,500,000 | $36,450,000 | 1.78% |
Sio Capital Management, LLC | 493,060 | $2,396,000 | 1.14% |
Rhenman & Partners Asset Management AB | 1,575,000 | $7,655,000 | 1.10% |
PFM Health Sciences, LP | 5,599,466 | $27,213,000 | 0.73% |
Elk Creek Partners, LLC | 2,087,238 | $10,144,000 | 0.66% |
Partner Investment Management, L.P. | 99,736 | $485,000 | 0.65% |
Brown Capital Management | 8,783,162 | $42,686,000 | 0.52% |